Highly Pure Deferoxamine CAS 70-51-9: Trusted Manufacturer & Supplier for Pharmaceutical and Research Needs

Discover Deferoxamine (CAS 70-51-9), a critical pharmaceutical intermediate and potent iron chelating agent. We are a leading manufacturer and supplier in China, offering high-purity Deferoxamine for diverse applications, including pharmaceutical production, research, and the treatment of metal toxicity. Explore our reliable supply chain and competitive pricing.

Get a Quote & Sample

Key Advantages of Sourcing Deferoxamine from Us

Uncompromising Quality and Purity

Our Deferoxamine (CAS 70-51-9) is manufactured under strict quality control protocols, ensuring exceptional purity for your critical applications. Trust our product as a reliable pharmaceutical intermediate.

Expert Sourcing and Competitive Pricing

Leveraging our strong position as a supplier in China, we offer competitive price points for Deferoxamine, making essential treatments and research more accessible.

Consistent and Stable Supply

We understand the importance of supply chain reliability. Partner with us to purchase Deferoxamine with the assurance of consistent availability for your ongoing needs.

Broad Applications of Deferoxamine

Treatment of Iron Overload

As a leading manufacturer, we provide Deferoxamine essential for managing chronic iron overload caused by frequent blood transfusions in conditions like thalassemia major and sickle cell disease. Explore options to buy this vital compound.

Acute Iron Poisoning Management

This high-purity iron chelator is crucial for emergency treatments of acute iron poisoning, aiding in the rapid removal of excess iron. Contact us for your urgent supply needs.

Aluminum Toxicity Treatment

Deferoxamine is also utilized in specific patient populations to manage aluminum toxicity, particularly in individuals undergoing dialysis. Our product ensures the efficacy required for such critical therapies.

Pharmaceutical Research and Development

Researchers and developers rely on our Deferoxamine as a key pharmaceutical intermediate for exploring new therapeutic avenues, including its role in inducing apoptosis and up-regulating HIF-1α.